Saiama Waqar

2025

Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A

Besse, B., Goto, K., Wang, Y., Lee, S. H., Marmarelis, M. E., Ohe, Y., Bernabe Caro, R., Kim, D. W., Lee, J. S., Cousin, S., Ichihara, E., Li, Y., Paz-Ares, L., Ono, A., Sanborn, R. E., Watanabe, N., de Miguel, M. J., Helissey, C., Shu, C. A. & Spira, A. I. & 23 others, Tomasini, P., Yang, J. C. H., Zhang, Y., Felip, E., Griesinger, F., Waqar, S. N., Calles, A., Neal, J. W., Baik, C. S., Jänne, P. A., Shreeve, S. M., Curtin, J. C., Patel, B., Gormley, M., Lyu, X., Chen, J., Chu, P. L., Mahoney, J., Trani, L., Bauml, J. M., Thayu, M., Knoblauch, R. E. & Cho, B. C., May 2025, In: Journal of Thoracic Oncology. 20, 5, p. 651-664 14 p.

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Integration of Clinical Trial Development in Hematology-Oncology Fellowship Training

Auberle, C., Wu, N., Dipersio, J. F., Waqar, S. N. & Ratner, L., Jan 1 2025, In: Academic Medicine. 100, 1, p. 38-41 4 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage SCLC: Results From TROPiCS-03

Dowlati, A., Chiang, A. C., Cervantes, A., Babu, S., Hamilton, E., Wong, S. F., Tazbirkova, A., Sullivan, I. G., van Marcke, C., Italiano, A., Patel, J., Mekan, S., Wu, T. & Waqar, S. N., Jun 2025, In: Journal of Thoracic Oncology. 20, 6, p. 799-808 10 p.

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Quality of life outcomes in patients participating in the CALGB 30610 trial (CALGB 70702): Alliance

Ganti, A. K., Fruth, B., Rimner, A., Waqar, S., Mix, M. D., Petty, W. J., Stinchcombe, T. E., Vokes, E. E., Bogart, J. A. & Dueck, A. C., Jan 1 2025, In: Cancer. 131, 1, e35663.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Toripalimab for Extensive-Stage Small Cell Lung Cancer

Cali Daylan, A. E., Morgensztern, D. & Waqar, S. N., Jan 16 2025, In: JAMA oncology. 11, 1, p. 26-27 2 p.

Research output: Contribution to journal › Comment/debate

2024

A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer

Auberle, C., Gao, F., Sloan, M., Morgensztern, D., Winkler, L., Ward, J. P., Devarakonda, S., Rearden, T. P., Govindan, R. & Waqar, S. N., Jun 30 2024, In: Journal of Thoracic Disease. 16, 6, p. 3782-3793 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial (Nature Medicine, (2022), 28, 10, (2155-2161), 10.1038/s41591-022-01962-5)

LCMC study investigators, Chaft, J. E., Oezkan, F., Kris, M. G., Bunn, P. A., Wistuba, I. I., Kwiatkowski, D. J., Owen, D. H., Tang, Y., Johnson, B. E., Lee, J. M., Lozanski, G., Pietrzak, M., Seweryn, M., Byun, W. Y., Schulze, K., Nicholas, A., Johnson, A., Grindheim, J. & Hilz, S. & 18 others, Shames, D. S., Rivard, C., Toloza, E., Haura, E. B., McNamee, C. J., Patterson, G. A., Waqar, S. N., Rusch, V. W., Carbone, D. P., Waqar, S. N., Shum, E., Nagasaka, M., Koczywas, M., Garon, E. B., Finley, D. J., Camidge, D. R., Carlisle, J. W. & Blasberg, J. D., Jan 2024, In: Nature medicine. 30, 1, p. 303 1 p.

Research output: Contribution to journal › Comment/debate

Open Access

4 Scopus citations

Factors associated with incomplete resection for large, locally invasive non-small cell lung cancer

Brandt, W. S., Yang, Z., Heiden, B. T., Samson, P. P., Morgensztern, D., Waqar, S. N., Meyers, B. F., Nava, R. G., Patterson, G. A., Kozower, B. D. & Puri, V., May 31 2024, In: Journal of Thoracic Disease. 16, 5, p. 2894-2905 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)

Kozono, D., Hua, X., Wu, M. C., Tolba, K. A., Waqar, S. N., Dragnev, K. H., Cheng, H., Hirsch, F. R., Mack, P. C., Gray, J. E., Kelly, K., Borghaei, H., Herbst, R. S., Gandara, D. R. & Redman, M. W., Dec 2024, In: Journal of Thoracic Oncology. 19, 12, p. 1618-1629 12 p.

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Novel Therapies in Cancer: Trials and Tribulations

Waqar, S. & Govindan, R., Sep 1 2024, In: Clinical Cancer Research. 30, 17, p. 3655-3657 3 p.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

The changing landscape of small cell lung cancer

Cittolin-Santos, G. F., Knapp, B., Ganesh, B., Gao, F., Waqar, S., Stinchcombe, T. E., Govindan, R. & Morgensztern, D., Jul 15 2024, In: Cancer. 130, 14, p. 2453-2461 9 p.

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

2023

High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538

Bogart, J., Wang, X., Masters, G., Gao, J., Komaki, R., Gaspar, L. E., Heymach, J., Bonner, J., Kuzma, C., Waqar, S., Petty, W., Stinchcombe, T. E., Bradley, J. D. & Vokes, E., May 1 2023, In: Journal of Clinical Oncology. 41, 13, p. 2394-2402 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

52 Scopus citations

Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma

Carneiro, B. A., Papadopoulos, K. P., Strickler, J. H., Lassman, A. B., Waqar, S. N., Chae, Y. K., Patel, J. D., Shacham-Shmueli, E., Kelly, K., Khasraw, M., Bestvina, C. M., Merrell, R., Huang, K., Atluri, H., Ansell, P., Li, R., Jin, J., Anderson, M. G., Reilly, E. B. & Morrison-Thiele, G. & 4 others, Patel, K., Robinson, R. R., Aristide, M. R. N. & Gan, H. K., Jan 1 2023, In: Neuro-Oncology Advances. 5, 1, vdac183.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Scopus citations

Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer

Semenkovich, N. P., Badiyan, S. N., Samson, P. P., Stowe, H. B., Wang, Y. E., Star, R., Devarakonda, S., Govindan, R., Waqar, S. N., Robinson, C. G., Vlacich, G., Pellini, B. & Chaudhuri, A. A., Dec 2023, In: npj Precision Oncology. 7, 1, 100.

Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations

Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)

Vaidya, R., Unger, J. M., Qian, L., Minichiello, K., Herbst, R. S., Gandara, D. R., Neal, J. W., Leal, T. A., Patel, J. D., Dragnev, K. H., Waqar, S. N., Edelman, M. J., Sigal, E. V., Adam, S. J., Malik, S., Blanke, C. D., Leblanc, M. L., Kelly, K., Gray, J. E. & Redman, M. W., Sep 1 2023, In: JCO Precision Oncology. 7, e2300218.

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non–small cell lung cancer

Rusch, V. W., Nicholas, A., Patterson, G. A., Waqar, S. N., Toloza, E. M., Haura, E. B., Raz, D. J., Reckamp, K. L., Merritt, R. E., Owen, D. H., Finley, D. J., McNamee, C. J., Blasberg, J. D., Garon, E. B., Mitchell, J. D., Doebele, R. C., Baciewicz, F., Nagasaka, M., Pass, H. I. & Schulze, K. & 9 others, Johnson, A., Bunn, P. A., Johnson, B. E., Kris, M. G., Kwiatkowski, D. J., Wistuba, I. I., Chaft, J. E., Carbone, D. P. & Lee, J. M., Mar 2023, In: Journal of Thoracic and Cardiovascular Surgery. 165, 3, p. 828-839.e5

Research output: Contribution to journal › Article › peer-review

Open Access

20 Scopus citations

Trajectories of participation in daily life among individuals newly diagnosed with cancer: A 5-month longitudinal study

L’Hotta, A. J., Yan, Y., Davis, A. A., Waqar, S. N., Chheda, M. G., Tan, B. R., Lyons, K. D., Park, Y. & King, A. A., Apr 2023, In: Supportive Care in Cancer. 31, 4, 213.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

Trends in Stage I Lung Cancer

Singareddy, A., Flanagan, M. E., Samson, P. P., Waqar, S. N., Devarakonda, S., Ward, J., Herzog, B. H., Rohatgi, A., Robinson, C., Gao, F., Govindan, R., Puri, V. & Morgensztern, D., Mar 2023, In: Clinical Lung Cancer. 24, 2, p. 114-119 6 p.

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

2022

Author Correction: Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors (Investigational New Drugs, (2022), 40, 3, (596-605), 10.1007/s10637-022-01216-8)

Waqar, S. N., Robinson, C., Olszanski, A. J., Spira, A., Hackmaster, M., Lucas, L., Sponton, L., Jin, H., Hering, U., Cronier, D., Grinberg, M., Seithel-Keuth, A., Diaz-Padilla, I. & Berlin, J., Jun 2022, In: Investigational New Drugs. 40, 3, p. 679 1 p.

Research output: Contribution to journal › Comment/debate

Open Access

1 Scopus citations

COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience

Mehta-Shah, N., Bartlett, N. L., Kahl, B., Watkins, M. P., Dubois, A., Schmelzle, G., Waqar, S., Ballman, C., Wan, F. & Farnsworth, C. W., 2022, In: Leukemia and Lymphoma. 63, 7, p. 1723-1727 5 p.

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer

Knapp, B., Mezquita, L., Devarakonda, S., Aldea, M., Waqar, S. N., Pepin, K., Ward, J. P., Botticella, A., Howarth, K., Knape, C., Morris, C., Govindan, R., Besse, B. & Morgensztern, D., Mar 28 2022, In: Frontiers in Oncology. 12, 856132.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

LCMC study investigators, Oct 2022, In: Nature medicine. 28, 10, p. 2155-2161 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

175 Scopus citations

Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors

Bagegni, N. A., Park, H., Kraft, K., O-Toole, M., Gao, F., Waqar, S. N., Ratner, L., Morgensztern, D., Devarakonda, S., Amin, M., Baggstrom, M. Q., Liang, C., Selvaggi, G. & Wang-Gillam, A., Apr 2022, In: Cancer Chemotherapy and Pharmacology. 89, 4, p. 487-497 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Scopus citations

Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer

Contreras, J., Srivastava, A., Samson, P., DeWees, T., Govindan, R., Baggstrom, M. Q., Morgensztern, D., Roach, M., Badiyan, S. N., Bradley, J., Waqar, S. & Robinson, C., Jul 15 2022, In: International Journal of Radiation Oncology Biology Physics. 113, 4, p. 742-748 7 p.

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors

Waqar, S. N., Robinson, C., Olszanski, A. J., Spira, A., Hackmaster, M., Lucas, L., Sponton, L., Jin, H., Hering, U., Cronier, D., Grinberg, M., Seithel-Keuth, A., Diaz-Padilla, I. & Berlin, J., Jun 2022, In: Investigational New Drugs. 40, 3, p. 596-605 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

33 Scopus citations

Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer

Bogart, J. A., Waqar, S. N. & Mix, M. D., Feb 20 2022, In: Journal of Clinical Oncology. 40, 6, p. 661-670 10 p.

Research output: Contribution to journal › Review article › peer-review

79 Scopus citations

Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint inhibitors

Herzog, B. H., Waqar, S. N., Devarakonda, S., Ward, J. P., Gao, F., Govindan, R. & Morgensztern, D., Nov 2022, In: Lung Cancer. 173, p. 101-106 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

2021

Adjuvant Therapy with EGFR Tyrosine Kinase Inhibitors: Tempering Great Expectations with Realism

Waqar, S. N. & Govindan, R., Mar 1 2021, In: Journal of Clinical Oncology. 39, 7, p. 697-700 4 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

2 Scopus citations

A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors

Mansfield, A. S., Hong, D. S., Hann, C. L., Farago, A. F., Beltran, H., Waqar, S. N., Hendifar, A. E., Anthony, L. B., Taylor, M. H., Bryce, A. H., Tagawa, S. T., Lewis, K., Niu, J., Chung, C. H., Cleary, J. M., Rossi, M., Ludwig, C., Valenzuela, R., Luo, Y. & Aggarwal, R., Dec 2021, In: npj Precision Oncology. 5, 1, 74.

Research output: Contribution to journal › Article › peer-review

Open Access

46 Scopus citations

A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations

Devarakonda, S., Pellini, B., Verghese, L., Park, H., Morgensztern, D., Govindan, R., Suresh, R., Oppelt, P., Baggstrom, M. Q., Wu, N. & Waqar, S. N., Jul 2021, In: Journal of Thoracic Disease. 13, 7, p. 4054-4062 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

13 Scopus citations

A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)

Waqar, S. N., Redman, M. W., Arnold, S. M., Hirsch, F. R., Mack, P. C., Schwartz, L. H., Gandara, D. R., Stinchcombe, T. E., Leighl, N. B., Ramalingam, S. S., Tanna, S. H., Raddin, R. S., Minichiello, K., Bradley, J. D., Kelly, K., Herbst, R. S. & Papadimitrakopoulou, V. A., May 2021, In: Clinical Lung Cancer. 22, 3, p. 170-177 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

54 Scopus citations

A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors

Park, H., Williams, K., Trikalinos, N. A., Larson, S., Tan, B., Waqar, S., Suresh, R., Morgensztern, D., Van Tine, B. A., Govindan, R., Luo, J., Lockhart, A. C. & Wang-Gillam, A., Mar 2021, In: Cancer Chemotherapy and Pharmacology. 87, 3, p. 337-347 11 p.

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Genomic Profiling of Lung Adenocarcinoma in Never-Smokers

Devarakonda, S., Li, Y., Martins Rodrigues, F., Sankararaman, S., Kadara, H., Goparaju, C., Lanc, I., Pepin, K., Waqar, S. N., Morgensztern, D., Ward, J., Masood, A., Fulton, R., Fulton, L., Gillette, M. A., Satpathy, S., Carr, S. A., Wistuba, I., Pass, H. & Wilson, R. K. & 2 others, Ding, L. & Govindan, R., Nov 20 2021, In: Journal of Clinical Oncology. 39, 33, p. 3747-3758 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

68 Scopus citations

Molecular profiling-based assignment of cancer therapy (NCI-MPACT): A randomized multicenter phase II trial

Chen, A. P., Kummar, S., Moore, N., Rubinstein, L. V., Zhao, Y., Williams, P. M., Palmisano, A., Sims, D., O'Sullivan Coyne, G., Rosenberger, C. L., Simpson, M., Raghav, K. P. S., Meric-Bernstam, F., Leong, S., Waqar, S., Foster, J. C., Konaté, M. M., Das, B., Karlovich, C. & Lih, C. J. & 5 others, Polley, E., Simon, R., Li, M. C., Piekarz, R. & Doroshow, J. H., Jan 2021, In: JCO Precision Oncology. 5, p. 133-144 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

36 Scopus citations

Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies

Lim, K. H., Opyrchal, M., Acharya, A., Boice, N., Wu, N., Gao, F., Webster, J., Lockhart, A. C., Waqar, S. N., Govindan, R., Morgensztern, D., Picus, J., Tan, B. R., Baggstrom, M. Q., Maher, C. A. & Wang-Gillam, A., Sep 2021, In: European Journal of Cancer. 154, p. 102-110 9 p.

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Small Cell Lung Cancer, Version 2.2022

Ganti, A. K. P., Loo, B. W., Bassetti, M., Blakely, C., Chiang, A., D'Amico, T. A., D'Avella, C., Dowlati, A., Downey, R. J., Edelman, M., Florsheim, C., Gold, K. A., Goldman, J. W., Grecula, J. C., Hann, C., Iams, W., Iyengar, P., Kelly, K., Khalil, M. & Koczywas, M. & 14 others, Merritt, R. E., Mohindra, N., Molina, J., Moran, C., Pokharel, S., Puri, S., Qin, A., Rusthoven, C., Sands, J., Santana-Davila, R., Shafique, M., Waqar, S. N., Gregory, K. M. & Hughes, M., Dec 2021, In: JNCCN Journal of the National Comprehensive Cancer Network. 19, 12, p. 1441-1464 24 p.

Research output: Contribution to journal › Article › peer-review

Open Access

279 Scopus citations

SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)

Borghaei, H., Redman, M. W., Kelly, K., Waqar, S. N., Robert, F., Kiefer, G. J., Stella, P. J., Minichiello, K., Gandara, D. R., Herbst, R. S. & Papadimitrakopoulou, V. A., May 2021, In: Clinical Lung Cancer. 22, 3, p. 178-186 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

2020

Demystifying the Role of Tumor Mutational Burden for Immunotherapy Selection - Reply

Waqar, S. N. & Govindan, R., 2020, In: JAMA oncology. 6, 11, p. 1809-1810 2 p.

Research output: Contribution to journal › Letter › peer-review

Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer

Hassanzadeh, C., Sita, T., Savoor, R., Samson, P. P., Bradley, J., Gentile, M., Roach, M., Mohindra, N., Waqar, S., Kruser, T. J. & Robinson, C., Nov 2020, In: Journal of Thoracic Disease. 12, 11, p. 6690-6700 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

34 Scopus citations

Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study

Domchek, S. M., Postel-Vinay, S., Im, S. A., Park, Y. H., Delord, J. P., Italiano, A., Alexandre, J., You, B., Bastian, S., Krebs, M. G., Wang, D., Waqar, S. N., Lanasa, M., Rhee, J., Gao, H., Rocher-Ros, V., Jones, E. V., Gulati, S., Coenen-Stass, A. & Kozarewa, I. & 5 others, Lai, Z., Angell, H. K., Opincar, L., Herbolsheimer, P. & Kaufman, B., Sep 2020, In: The Lancet Oncology. 21, 9, p. 1155-1164 10 p.

Research output: Contribution to journal › Article › peer-review

369 Scopus citations

Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy

Arnold, S. M., Chansky, K., Baggstrom, M. Q., Thompson, M. A., Sanborn, R. E., Villano, J. L., Waqar, S. N., Hamm, J., Leggas, M., Willis, M., Rosales, J. & Crowley, J. J., Jul 2020, In: Clinical Lung Cancer. 21, 4, p. 357-364.e7

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

The Mystic Role of Tumor Mutational Burden in Selecting Patients with Lung Cancer for First-Line Immunotherapy

Waqar, S. N. & Govindan, R., May 2020, In: JAMA oncology. 6, 5, p. 674-675 2 p.

Research output: Contribution to journal › Comment/debate

6 Scopus citations

2019

Association between depth of response and survival in patients with advanced-stage non–small cell lung cancer treated with first-line chemotherapy

Morgensztern, D., Ko, A., O’Brien, M., Ong, T. J., Waqar, S. N., Socinski, M. A., Postmus, P. E. & Bhore, R., Jul 15 2019, In: Cancer. 125, 14, p. 2394-2399 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Scopus citations

Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)

Horn, L., Whisenant, J. G., Wakelee, H., Reckamp, K. L., Qiao, H., Du, L., Hernandez, J., Huang, V., Waqar, S. N., Patel, S., Sanborn, R. E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K., Liang, C., Lim, L. P., Li, M. & Lovly, C. M., Apr 2019, In: Annals of Oncology. 30, p. ii48

Research output: Contribution to journal › Article › peer-review

Open Access

Circulating tumor DNA profiling in small-cell lung cancer identifies potentially targetable alterations

Devarakonda, S., Sankararaman, S., Herzog, B. H., Gold, K. A., Waqar, S. N., Ward, J. P., Raymond, V. M., Lanman, R. B., Chaudhuri, A. A., Owonikoko, T. K., Li, B. T., Poirier, J. T., Rudin, C. M., Govindan, R. & Morgensztern, D., Oct 15 2019, In: Clinical Cancer Research. 25, 20, p. 6119-6126 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

45 Scopus citations

Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer

Horn, L., Whisenant, J. G., Wakelee, H., Reckamp, K. L., Qiao, H., Leal, T. A., Du, L., Hernandez, J., Huang, V., Blumenschein, G. R., Waqar, S. N., Patel, S. P., Nieva, J., Oxnard, G. R., Sanborn, R. E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K. & Liang, C. & 3 others, Lim, L. P., Li, M. & Lovly, C. M., Nov 2019, In: Journal of Thoracic Oncology. 14, 11, p. 1901-1911 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

149 Scopus citations

Optimizing Targeted Therapies Using Next-Generation Sequencing

Herzog, B. H. & Waqar, S. N., Jan 1 2019, Cancer Genomics for the Clinician. Springer Publishing Company, p. 127-164 38 p.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer

Morgensztern, D., Rose, M., Waqar, S. N., Morris, J., Ma, P. C., Reid, T., Brzezniak, C. E., Zeman, K. G., Padmanabhan, A., Hirth, J. A., I. Spira, A., Trepel, J. B. & Padda, S. K., Jul 30 2019, In: British Journal of Cancer. 121, 3, p. 211-217 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

38 Scopus citations

SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Edelman, M. J., Redman, M. W., Albain, K. S., McGary, E. C., Rafique, N. M., Petro, D., Waqar, S. N., Minichiello, K., Miao, J., Papadimitrakopoulou, V. A., Kelly, K., Gandara, D. R. & Herbst, R. S., Oct 2019, In: Journal of Thoracic Oncology. 14, 10, p. 1853-1859 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

61 Scopus citations

2018

A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer and Systemic Inflammation

Giaccone, G., Sanborn, R. E., Waqar, S. N., Martinez-Marti, A., Ponce, S., Zhen, H., Kennealey, G., Erickson-Viitanen, S. & Schaefer, E., Sep 2018, In: Clinical Lung Cancer. 19, 5, p. e567-e574

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Saiama Waqar

Research output

Search results